SIGMAPHARM Trademark

Trademark Overview

On Monday, April 13, 2009, a trademark application was filed for SIGMAPHARM with the United States Patent and Trademark Office. The USPTO has given the SIGMAPHARM trademark a serial number of 77978762. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, June 1, 2023. This trademark is owned by SigmaPharm Laboratories, LLC. The SIGMAPHARM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development of pharmaceutical products and preparations for the treatment of hypertension, depression, thyroid deficiency syndrome, hepatitis and, HIV and fungal infections
sigmapharm

General Information

Serial Number77978762
Word MarkSIGMAPHARM
Filing DateMonday, April 13, 2009
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, June 1, 2023
Registration Number5119590
Registration DateTuesday, January 10, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2010

Trademark Statements

Pseudo MarkSIGMA PHARM; SIGMA PHARMACEUTICAL
Goods and Servicesresearch and development of pharmaceutical products and preparations for the treatment of hypertension, depression, thyroid deficiency syndrome, hepatitis and, HIV and fungal infections

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 16, 2009
Primary Code042
First Use Anywhere DateSaturday, December 31, 2005
First Use In Commerce DateSaturday, December 31, 2005

Trademark Owner History

Party NameSigmaPharm Laboratories, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBensalem, PA 19020
Party NameSigmaPharm Laboratories, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBensalem, PA 19020
Party NameSigmaPharm Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBensalem, PA 19020

Trademark Events

Event DateEvent Description
Thursday, June 1, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, June 1, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, June 1, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 31, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 31, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 31, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 22, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, January 10, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 10, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, December 6, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 5, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 1, 2016NOTICE OF PSEUDO MARK E-MAILED
Wednesday, November 30, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, November 21, 2016USE AMENDMENT FILED
Wednesday, November 30, 2016DIVISIONAL PROCESSING COMPLETE
Monday, November 21, 2016DIVISIONAL REQUEST RECEIVED
Wednesday, November 23, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 21, 2016TEAS REQUEST TO DIVIDE RECEIVED
Monday, November 21, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, November 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 14, 2016SOU EXTENSION 3 GRANTED
Monday, November 7, 2016SOU EXTENSION 3 FILED
Monday, November 7, 2016TEAS EXTENSION RECEIVED
Friday, July 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 14, 2016SOU EXTENSION 2 GRANTED
Sunday, June 5, 2016SOU EXTENSION 2 FILED
Wednesday, July 6, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, June 5, 2016TEAS EXTENSION RECEIVED
Tuesday, December 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 27, 2015SOU EXTENSION 1 GRANTED
Friday, November 27, 2015SOU EXTENSION 1 FILED
Friday, November 27, 2015TEAS EXTENSION RECEIVED
Tuesday, June 9, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 27, 2015TTAB RELEASE CASE TO TRADEMARKS
Monday, April 27, 2015OPPOSITION TERMINATED NO. 999999
Monday, February 9, 2015OPPOSITION DISMISSED NO. 999999
Friday, October 15, 2010OPPOSITION TERMINATED NO. 999999
Friday, October 15, 2010OPPOSITION DISMISSED NO. 999999
Wednesday, October 6, 2010OPPOSITION INSTITUTED NO. 999999
Wednesday, October 6, 2010OPPOSITION INSTITUTED NO. 999999
Wednesday, October 6, 2010OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, September 7, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2010PUBLISHED FOR OPPOSITION
Monday, August 2, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 2, 2010ASSIGNED TO LIE
Tuesday, July 20, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 13, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 13, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 13, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 13, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 13, 2010NON-FINAL ACTION E-MAILED
Wednesday, January 13, 2010NON-FINAL ACTION WRITTEN
Thursday, December 31, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 31, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 31, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 1, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2009NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2009NON-FINAL ACTION WRITTEN
Monday, June 29, 2009ASSIGNED TO EXAMINER
Friday, April 17, 2009NOTICE OF PSEUDO MARK MAILED
Thursday, April 16, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 16, 2009NEW APPLICATION ENTERED

Related Keywords

sigmapharm deficiency thyroid syndrome hepatitis infections fungal depression hypertension pharmaceutical development